Prognostic factors for patients treated with abiraterone.
Saved in:
| Title: | Prognostic factors for patients treated with abiraterone. |
|---|---|
| Authors: | Alvim CM; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Mansinho A; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal., Paiva RS; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Brás R; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Semedo PM; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Lobo-Martins S; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., da Ponte CB; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Macedo D; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Ribeiro L; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Dos Reis JP; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal., Fernandes I; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal., Costa L; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal. |
| Source: | Future science OA [Future Sci OA] 2019 Dec 12; Vol. 6 (2), pp. FSO436. Date of Electronic Publication: 2019 Dec 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101665030 Publication Model: Electronic Cited Medium: Print ISSN: 2056-5623 (Print) Linking ISSN: 20565623 NLM ISO Abbreviation: Future Sci OA Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32025327 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic factors for patients treated with abiraterone. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alvim+CM%22">Alvim CM</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Mansinho+A%22">Mansinho A</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Paiva+RS%22">Paiva RS</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Brás+R%22">Brás R</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Semedo+PM%22">Semedo PM</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Lobo-Martins+S%22">Lobo-Martins S</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22da+Ponte+CB%22">da Ponte CB</searchLink>; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Macedo+D%22">Macedo D</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Ribeiro+L%22">Ribeiro L</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Dos+Reis+JP%22">Dos Reis JP</searchLink>; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.<br /><searchLink fieldCode="AU" term="%22Fernandes+I%22">Fernandes I</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Costa+L%22">Costa L</searchLink>; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, 1649-035, Portugal.; Luís Costa Lab, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101665030%22">Future science OA</searchLink> [Future Sci OA] 2019 Dec 12; Vol. 6 (2), pp. FSO436. <i>Date of Electronic Publication: </i>2019 Dec 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101665030 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2056-5623 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220565623%22">20565623 </searchLink><i>NLM ISO Abbreviation: </i>Future Sci OA <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32025327 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2144/fsoa-2019-0079 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: FSO436 Titles: – TitleFull: Prognostic factors for patients treated with abiraterone. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alvim CM – PersonEntity: Name: NameFull: Mansinho A – PersonEntity: Name: NameFull: Paiva RS – PersonEntity: Name: NameFull: Brás R – PersonEntity: Name: NameFull: Semedo PM – PersonEntity: Name: NameFull: Lobo-Martins S – PersonEntity: Name: NameFull: da Ponte CB – PersonEntity: Name: NameFull: Macedo D – PersonEntity: Name: NameFull: Ribeiro L – PersonEntity: Name: NameFull: Dos Reis JP – PersonEntity: Name: NameFull: Fernandes I – PersonEntity: Name: NameFull: Costa L IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 12 Text: 2019 Dec 12 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 2056-5623 Numbering: – Type: volume Value: 6 – Type: issue Value: 2 Titles: – TitleFull: Future science OA Type: main |
| ResultId | 1 |